ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,066.00
-0.07%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36175
0.02%
Bitcoin
67,020.12
-0.09%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Talaris Therapeutics Inc (TALS)

  7. Talaris Therapeutics Inc (TALS) News

TALS

Talaris Therapeutics (TALS)

Talaris Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TALS
DateTimeSourceHeadlineSymbolCompany
04/19/20243:05PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TALSTalaris Therapeutics Inc
04/19/20243:04PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TALSTalaris Therapeutics Inc
04/19/20243:02PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TALSTalaris Therapeutics Inc
03/19/20244:10PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TALSTalaris Therapeutics Inc
03/19/20244:02PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TALSTalaris Therapeutics Inc
03/19/20246:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TALSTalaris Therapeutics Inc
11/20/20235:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TALSTalaris Therapeutics Inc
11/20/20235:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TALSTalaris Therapeutics Inc
11/06/20233:30PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TALSTalaris Therapeutics Inc
10/30/20233:15PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TALSTalaris Therapeutics Inc
10/27/20234:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TALSTalaris Therapeutics Inc
10/27/20233:02PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TALSTalaris Therapeutics Inc
10/26/20234:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TALSTalaris Therapeutics Inc
10/26/20234:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TALSTalaris Therapeutics Inc
10/26/20233:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TALSTalaris Therapeutics Inc
10/20/20238:23PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TALSTalaris Therapeutics Inc
10/17/20234:47PMGlobeNewswire Inc.Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline BioNASDAQ:TALSTalaris Therapeutics Inc
10/10/20233:32PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:TALSTalaris Therapeutics Inc
10/10/20233:30PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TALSTalaris Therapeutics Inc
10/06/20237:01PMDow Jones NewsStocks to Watch: Shift Technologies, Talaris Therapeutics, Lockheed MartinNASDAQ:TALSTalaris Therapeutics Inc
10/06/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TALSTalaris Therapeutics Inc
10/06/20234:27PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:TALSTalaris Therapeutics Inc
10/06/20234:26PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TALSTalaris Therapeutics Inc
10/06/20234:09PMGlobeNewswire Inc.Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline BioNASDAQ:TALSTalaris Therapeutics Inc
10/04/20237:30AMGlobeNewswire Inc.New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris TherapeuticsNASDAQ:TALSTalaris Therapeutics Inc
09/26/20237:24AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:TALSTalaris Therapeutics Inc
09/26/20237:21AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TALSTalaris Therapeutics Inc
09/15/20235:31AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TALSTalaris Therapeutics Inc
09/14/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TALSTalaris Therapeutics Inc
09/13/20233:28PMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:TALSTalaris Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TALS

Your Recent History

AMEX
XHYF
BondBloxx USD High Yield...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved